NCT01407172View on ClinicalTrials.gov

Hydrogen Sulfide and Peripheral Arterial Disease

CompletedOBSERVATIONAL
Enrollment

252

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions
Peripheral Arterial Disease
Trial Locations (1)

71130

LSUHSC Shreveport, Shreveport

All Listed Sponsors
lead

Louisiana State University Health Sciences Center Shreveport

OTHER

NCT01407172 - Hydrogen Sulfide and Peripheral Arterial Disease | Biotech Hunter | Biotech Hunter